Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lactoserum
- Development stage
- Phase 4
- Lead developer
- Sanofi
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Topical, Oral
01
Overview
Lactoserum is a protein component derived from milk whey, often characterized as a "fast protein" due to its ability to rapidly increase peripheral amino acid bioavailability. This property has led to its investigation for improving muscle protein synthesis, particularly in aged individuals, and in combination with other compounds like citrulline. Additionally, lactoserum is utilized as an active ingredient in feminine hygiene products, such as the Dermacyd Femina line, where it has undergone dermatological safety and acceptability evaluations. It has also been studied for its potential role in preventing the recurrence of bacterial vaginosis.
- Brand names
- Dermacyd FeminaDermacyd Femina DelicataDermacyd Wipes
Beyond the preview
Go deeper on lactoserum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lactoserum.